http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101995612-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0031 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0078 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-452 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-452 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-72 |
filingDate | 2013-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101995612-B1 |
titleOfInvention | Ameliorating agent for chronic obstructive pulmonary disease |
abstract | The present invention provides a safe and effective agent for improving chronic obstructive pulmonary disease (COPD), which has both bronchodilating action and anti-inflammatory action, and is useful as a therapeutic agent for chronic obstructive pulmonary disease And more preferably the dosage form is a chronic obstructive pulmonary disease-improving agent administered in Kyunggi Province or inhalation administration. Also, the dosage form is a chronic obstructive pulmonary disease-improving agent which is administered orally or rectally, and mefenazolate bromide (COPD), which has both bronchodilating action and anti-inflammatory action. |
priorityDate | 2012-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 124.